Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654366 · ClinicalTrials.gov registry record · NA
Community Supported Risk Reduction for Syringe Exchange Participants
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT02654366: Completed NA study, sponsored by Johns Hopkins University.
NCT02654366 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 87 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02654366, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
Efforts to help syringe exchange registrants employ additional HIV risk reduction strategies are often thwarted by strong social networks that reinforce substance use and other risky injection use and sexual behaviors. The proposed study addresses this important problem by evaluating the feasibility and efficacy of a novel Community Supported Risk Reduction group. This structured intervention works with injection drug users and at least one drug-free family or friend to mobilize social support, teach HIV risk reduction skills, develop treatment readiness, and support participation in community activities designed to expand drug-free social networks.
Interventions
- BEHAVIORAL Risk Reduction Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2016-05 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02654366
The ClinicalTrials.gov registry entry for NCT02654366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Risk Reduction Group is the first listed.
NCT02654366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02654366 about?
NCT02654366 is a clinical study titled "Community Supported Risk Reduction for Syringe Exchange Participants". Efforts to help syringe exchange registrants employ additional HIV risk reduction strategies are often thwarted by strong social networks that reinforce substance use and other risky injection use and sexual behaviors. The proposed study addresses this important problem by evaluating the feasibility...
What is the current status of trial NCT02654366?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2016-05. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT02654366?
The interventions under investigation include: Risk Reduction Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02654366?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.